title: Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis.
authors.forename: W Y
authors.initials: WY
authors.lastname: Au
authors.forename: A
authors.initials: A
authors.lastname: Fung
authors.forename: A K
authors.initials: AK
authors.lastname: Lie
authors.forename: K Y
authors.initials: KY
authors.lastname: Lam
authors.forename: C C
authors.initials: CC
authors.lastname: Lam
authors.forename: Y L
authors.initials: YL
authors.lastname: Kwong
mesh_terms: D016026:Bone Marrow Transplantation; D006086:Graft vs Host Disease; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics / Q000378:metabolism*; D007938:Leukemia / Q000201:enzymology* / Q000235:genetics / Q000473:pathology* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D010649:Phenylalanine / Q000235:genetics / Q000378:metabolism*; D012008:Recurrence; D013920:Thrombocythemia, Essential / Q000201:enzymology* / Q000235:genetics / Q000473:pathology / Q000601:surgery*; D017211:Treatment Failure; D014633:Valine / Q000235:genetics / Q000378:metabolism*
chemical_list: D010649:Phenylalanine; D053614:Janus Kinase 2; D014633:Valine